nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.071	0.14	CcSEcCtD
Bimatoprost—Common cold—Lisinopril—dilated cardiomyopathy	0.0422	0.0831	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0157	0.0318	CbGpPWpGaD
Bimatoprost—Bladder pain—Furosemide—dilated cardiomyopathy	0.0133	0.0261	CcSEcCtD
Bimatoprost—Cough increased—Lisinopril—dilated cardiomyopathy	0.012	0.0237	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0117	0.0238	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0115	0.0233	CbGpPWpGaD
Bimatoprost—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.0108	0.0212	CcSEcCtD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0107	0.0216	CbGpPWpGaD
Bimatoprost—Cystitis—Lisinopril—dilated cardiomyopathy	0.0106	0.021	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0105	0.0214	CbGpPWpGaD
Bimatoprost—Photophobia—Lisinopril—dilated cardiomyopathy	0.0103	0.0204	CcSEcCtD
Bimatoprost—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00996	0.0196	CcSEcCtD
Bimatoprost—Somnolence—Spironolactone—dilated cardiomyopathy	0.00856	0.0169	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00831	0.0164	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00827	0.0168	CbGpPWpGaD
Bimatoprost—Arthritis—Lisinopril—dilated cardiomyopathy	0.00822	0.0162	CcSEcCtD
Bimatoprost—Diplopia—Lisinopril—dilated cardiomyopathy	0.00799	0.0158	CcSEcCtD
Bimatoprost—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00715	0.0141	CcSEcCtD
Bimatoprost—Visual impairment—Furosemide—dilated cardiomyopathy	0.0071	0.014	CcSEcCtD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00709	0.0144	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00709	0.0144	CbGpPWpGaD
Bimatoprost—Asthma—Lisinopril—dilated cardiomyopathy	0.00691	0.0136	CcSEcCtD
Bimatoprost—Eye disorder—Furosemide—dilated cardiomyopathy	0.00689	0.0136	CcSEcCtD
Bimatoprost—Pruritus—Spironolactone—dilated cardiomyopathy	0.00681	0.0134	CcSEcCtD
Bimatoprost—Angiopathy—Furosemide—dilated cardiomyopathy	0.00669	0.0132	CcSEcCtD
Bimatoprost—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00664	0.0131	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0066	0.0134	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00659	0.0134	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00658	0.0134	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00642	0.0127	CcSEcCtD
Bimatoprost—Erythema—Furosemide—dilated cardiomyopathy	0.00642	0.0126	CcSEcCtD
Bimatoprost—Dizziness—Spironolactone—dilated cardiomyopathy	0.00636	0.0125	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0062	0.0126	CbGpPWpGaD
Bimatoprost—Depression—Lisinopril—dilated cardiomyopathy	0.00614	0.0121	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00612	0.0124	CbGpPWpGaD
Bimatoprost—Rash—Spironolactone—dilated cardiomyopathy	0.00607	0.012	CcSEcCtD
Bimatoprost—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00606	0.0119	CcSEcCtD
Bimatoprost—Vision blurred—Furosemide—dilated cardiomyopathy	0.00605	0.0119	CcSEcCtD
Bimatoprost—Headache—Spironolactone—dilated cardiomyopathy	0.00603	0.0119	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00593	0.012	CbGpPWpGaD
Bimatoprost—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00578	0.0114	CcSEcCtD
Bimatoprost—Vertigo—Furosemide—dilated cardiomyopathy	0.00576	0.0114	CcSEcCtD
Bimatoprost—Nausea—Spironolactone—dilated cardiomyopathy	0.00572	0.0113	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00564	0.0115	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00564	0.0115	CbGpPWpGaD
Bimatoprost—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00554	0.0109	CcSEcCtD
Bimatoprost—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00549	0.0108	CcSEcCtD
Bimatoprost—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00545	0.0107	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00542	0.0107	CcSEcCtD
Bimatoprost—Dry mouth—Furosemide—dilated cardiomyopathy	0.00534	0.0105	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00524	0.0106	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00514	0.0101	CcSEcCtD
Bimatoprost—Skin disorder—Furosemide—dilated cardiomyopathy	0.00509	0.01	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00508	0.0103	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00506	0.0103	CbGpPWpGaD
Bimatoprost—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00502	0.00989	CcSEcCtD
Bimatoprost—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00498	0.00982	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00492	0.01	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0049	0.00994	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00482	0.00978	CbGpPWpGaD
Bimatoprost—Erythema—Lisinopril—dilated cardiomyopathy	0.00481	0.00949	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0048	0.00975	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00479	0.00973	CbGpPWpGaD
Bimatoprost—Tension—Lisinopril—dilated cardiomyopathy	0.00472	0.00931	CcSEcCtD
Bimatoprost—Nervousness—Lisinopril—dilated cardiomyopathy	0.00468	0.00921	CcSEcCtD
Bimatoprost—Somnolence—Furosemide—dilated cardiomyopathy	0.00466	0.00917	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00458	0.00929	CbGpPWpGaD
Bimatoprost—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00454	0.00894	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00452	0.00891	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00448	0.0091	CbGpPWpGaD
Bimatoprost—Pain—Furosemide—dilated cardiomyopathy	0.00448	0.00882	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00443	0.009	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00438	0.00889	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00434	0.00881	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00434	0.00881	CbGpPWpGaD
Bimatoprost—Vertigo—Lisinopril—dilated cardiomyopathy	0.00433	0.00852	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0043	0.00872	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0043	0.00872	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00429	0.0087	CbGpPWpGaD
Bimatoprost—Palpitations—Lisinopril—dilated cardiomyopathy	0.00425	0.00838	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00422	0.00856	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00422	0.00856	CbGpPWpGaD
Bimatoprost—Cough—Lisinopril—dilated cardiomyopathy	0.0042	0.00828	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00413	0.00838	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00413	0.00838	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00411	0.00835	CbGpPWpGaD
Bimatoprost—Chest pain—Lisinopril—dilated cardiomyopathy	0.0041	0.00808	CcSEcCtD
Bimatoprost—Anxiety—Lisinopril—dilated cardiomyopathy	0.00408	0.00805	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00407	0.00802	CcSEcCtD
Bimatoprost—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00401	0.0079	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00399	0.00811	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00392	0.00796	CbGpPWpGaD
Bimatoprost—Infection—Lisinopril—dilated cardiomyopathy	0.0039	0.00769	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00387	0.00785	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00384	0.00779	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00384	0.00779	CbGpPWpGaD
Bimatoprost—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00382	0.00752	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0038	0.00771	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00379	0.00769	CbGpPWpGaD
Bimatoprost—Asthenia—Furosemide—dilated cardiomyopathy	0.00376	0.0074	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00372	0.00755	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00371	0.00752	CbGpPWpGaD
Bimatoprost—Pruritus—Furosemide—dilated cardiomyopathy	0.0037	0.0073	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00359	0.00729	CbGpPWpGaD
Bimatoprost—Insomnia—Lisinopril—dilated cardiomyopathy	0.00355	0.007	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00352	0.00714	CbGpPWpGaD
Bimatoprost—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0035	0.0069	CcSEcCtD
Bimatoprost—Somnolence—Lisinopril—dilated cardiomyopathy	0.00349	0.00688	CcSEcCtD
Bimatoprost—Dizziness—Furosemide—dilated cardiomyopathy	0.00346	0.00682	CcSEcCtD
Bimatoprost—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00346	0.00681	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00345	0.007	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00339	0.00668	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00337	0.00685	CbGpPWpGaD
Bimatoprost—Pain—Lisinopril—dilated cardiomyopathy	0.00336	0.00662	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0033	0.00671	CbGpPWpGaD
Bimatoprost—Rash—Furosemide—dilated cardiomyopathy	0.0033	0.00651	CcSEcCtD
Bimatoprost—Dermatitis—Furosemide—dilated cardiomyopathy	0.0033	0.0065	CcSEcCtD
Bimatoprost—Headache—Furosemide—dilated cardiomyopathy	0.00328	0.00646	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00324	0.00659	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00321	0.00652	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00321	0.00652	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00317	0.00645	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00314	0.00638	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00314	0.00638	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00313	0.00636	CbGpPWpGaD
Bimatoprost—Nausea—Furosemide—dilated cardiomyopathy	0.00311	0.00613	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00308	0.00626	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00308	0.00625	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00305	0.0062	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00302	0.00613	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00301	0.00612	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00299	0.00606	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00294	0.00597	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00292	0.00593	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00289	0.00587	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00283	0.00575	CbGpPWpGaD
Bimatoprost—Asthenia—Lisinopril—dilated cardiomyopathy	0.00282	0.00555	CcSEcCtD
Bimatoprost—Pruritus—Lisinopril—dilated cardiomyopathy	0.00278	0.00548	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—TAZ—dilated cardiomyopathy	0.00276	0.00561	CbGpPWpGaD
Bimatoprost—Dizziness—Lisinopril—dilated cardiomyopathy	0.0026	0.00512	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—SDHA—dilated cardiomyopathy	0.0025	0.00507	CbGpPWpGaD
Bimatoprost—Rash—Lisinopril—dilated cardiomyopathy	0.00248	0.00488	CcSEcCtD
Bimatoprost—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00247	0.00488	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00247	0.00501	CbGpPWpGaD
Bimatoprost—Headache—Lisinopril—dilated cardiomyopathy	0.00246	0.00485	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00243	0.00493	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00243	0.00493	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00242	0.00491	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00234	0.00476	CbGpPWpGaD
Bimatoprost—Nausea—Lisinopril—dilated cardiomyopathy	0.00233	0.0046	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00232	0.00472	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00229	0.00466	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00228	0.00463	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00226	0.00458	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00223	0.00454	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0022	0.00448	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0022	0.00448	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00219	0.00444	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00214	0.00434	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00209	0.00425	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00205	0.00416	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00198	0.00403	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00187	0.00379	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00182	0.00369	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00182	0.00369	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00178	0.00361	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00178	0.00361	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00177	0.0036	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00174	0.00353	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0017	0.00345	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00169	0.00344	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00169	0.00343	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00165	0.00335	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00165	0.00335	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00165	0.00335	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00163	0.00332	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00161	0.00328	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00161	0.00328	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00161	0.00326	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.0016	0.00325	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00153	0.00311	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NPPA—dilated cardiomyopathy	0.00153	0.0031	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00152	0.00309	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.0015	0.00305	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00148	0.00301	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00148	0.00301	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSEN2—dilated cardiomyopathy	0.00148	0.003	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00147	0.00298	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00147	0.00298	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00145	0.00295	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00144	0.00292	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0014	0.00283	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00137	0.00279	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00137	0.00277	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00134	0.00271	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00132	0.00269	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00131	0.00267	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.0013	0.00264	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.0013	0.00264	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.0013	0.00263	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00127	0.00257	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00125	0.00253	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00124	0.00252	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00121	0.00246	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0012	0.00244	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00119	0.00242	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00118	0.00239	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00117	0.00238	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0011	0.00223	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00107	0.00218	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00104	0.0021	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00103	0.00209	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00101	0.00204	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.001	0.00203	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000982	0.00199	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000974	0.00198	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000974	0.00198	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000961	0.00195	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000953	0.00194	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000953	0.00194	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00095	0.00193	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000933	0.0019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000919	0.00187	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000919	0.00187	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000914	0.00186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000905	0.00184	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000892	0.00181	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000886	0.0018	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000877	0.00178	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000873	0.00177	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000858	0.00174	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000855	0.00174	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000828	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000828	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000816	0.00166	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000749	0.00152	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAC1—dilated cardiomyopathy	0.000744	0.00151	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000737	0.0015	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000733	0.00149	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00071	0.00144	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000707	0.00144	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000705	0.00143	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000695	0.00141	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX1—dilated cardiomyopathy	0.000679	0.00138	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000671	0.00136	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CD36—dilated cardiomyopathy	0.000661	0.00134	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000619	0.00126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00061	0.00124	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000606	0.00123	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000597	0.00121	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AGT—dilated cardiomyopathy	0.000595	0.00121	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000576	0.00117	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000568	0.00115	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000551	0.00112	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00054	0.0011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000527	0.00107	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000521	0.00106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000516	0.00105	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000498	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAF1—dilated cardiomyopathy	0.000493	0.001	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000489	0.000993	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000424	0.000862	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000415	0.000844	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000366	0.000742	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000358	0.000727	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000345	0.000701	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—dilated cardiomyopathy	0.000338	0.000687	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000335	0.000681	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000251	0.000509	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000245	0.000498	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000237	0.000481	CbGpPWpGaD
